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ISSUE I

PAGE ONE
Our cover story: The 4th Annual Women's
Leadership Luncheon to support The AIDS Project is
a big success.

The 4th Annual Women's Leadership Luncheon to benefit The AIDS
Project was held on October 6th at the Marriot at Sable Oaks in South PAGE TWO
Portland. This year's event was co-chaired by Donna Mundy and Terry In the monthly "By The Way" from Mike Martin, our
Cohen of the UNUM Corporation, which was the Gold Ribbon sponsor of editor puts together his usual potpourri of news and
the event. Mary J. Herman, the first lady of the State of Maine, was the comment.
And HIV News.
honorary chair.
Receiving the Kerry A. Carson Memorial Awards were Cathy Kidman, PAGE THREE
Executive Director of Outright (an organization serving gay, lesbian, HIV News from around the world, across the nation,
bisexual, and transgendered young people ages 22 and under), and Mary and in our state.
Ruchinskas, Community Services Director ofNew Beginnings in Lewiston PAGE FOUR
(an organization serving youth who are runaways, homeless, or in high risk More HIV News.
situations). Both recipients spoke to the need of reaching out to youth to A call to clients concerning support groups at TAP.
prevent the further spread of HIV, which already disproportionately affects
PAGE FIVE
people under the age of25.
Reviewing Client Rights and the Client Grievance
The Kerry A. Carson Memorial Awards pays tribute to Kerry Anne Procedures.
Carson ofYork, Maine, who contracted HIV at the age of 15 and later died of
AIDS. Past recipients of the award include Kerry (posthumously), Frannie PAGE SIX
Standard Dosing Schedule for Anti-HIV Drugs, from
Peabody, Lani Graham, and Elizabeth Watson.
Project Inform.
Also participating was George Friou, TAP's Executive Director, who
thanked all the sponsors, volunteers, and attendees for their support of PAGE SEVEN
people with HIVIAIDS. Stacy Bachelder from Telstar High School spoke to Client Services, Support Groups, and For Your
the crowd about her school's efforts to raise AIDS awareness and about her Information.
school's yearly fundraising benefit for a deserving AIDS organization. PAGE EIGHT
Mary Crothers and Bart Giamatti from Waynefleet School Students for TAP Listings, including: TAP Locations, Staff, Board
Safer Sexuality performed an enlightening, yet humorous sketch concern- Members, and Advisory Board Members.
ing safer sex. A sketch they would normally be presenting to their peers.
Karla McGowan was singled out for all her hard work on the luncheon. We welcome David Swander to TAP as
Karla is a member ofTAP's Board of Directors and chair of its Fundraising an Administrative I Development
Assistant. And we wish a fond farewell
& Public Relations Committee
to
Rodney Mondor, formerly TAP's
It was announced at the sold-out luncheon that the event had raised
Volunteer Services Coordinator, who has
$18,000 for The AIDS Project. All in all, the Women's Leadership
left TAP for a job at USM.
Luncheon has become an important annual area event to raise awareness of
HIV/AIDS.
·-A~
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Teenagers in Turmoil

USA Today (10/05/98)
Many teenage deaths each year are avoidable, with
approximately 10,000 of the 37,000 deaths among young
people related to murder, suicide, or AIDS complications.
HIV is increasingly becoming a problem among young
people in the United States. The CDC says around 50% of
the 40,000 new HIV cases in the U.S. occur in people under
the age of 25. The CDC Youth Risk Behavior Surveillance
Survey recently concluded that many teens were engaging
in risky behaviors. Steve Small, a professor at the University
of Michigan, also notes, ''They [adolescents] do things like
drink and smoke and become sexually active".
Despite widespread behavioral risks taken by teens, a
CDC study indicates that sexual activity has declined
among high school students for the first time in 20 years
and that fewer students report having sex with a series of
partners. The study of more than 10,000 students also
shows that sexually active students were using condoms
more often. Even though there has been a decline, one-tenth
of all adolescents are sexually active before age 13,
according to Janet Collins of the CDC. Suggestions from
students at a recent CDC-sponsored meeting in Atlanta
included increased positive role-modeling by parents and
additional education initiatives.
The Need for Improved Data on HIV Is Critical
Boston Globe (10/03/98)
Dr. Helene Gayle, of the CDC, asserts that some people
have misinterpreted recent data on the HIV/AIDS epidemic.
In a letter to the Boston Globe, Gayle notes that while the
number of AIDS cases and deaths have declined, there is an
increasing number of people living with HIV due to new
treatments that slow disease progression. She points out
that statistics on AIDS cases and deaths are important
indicators of the epidemic among some groups of people for
whom treatment is unavailable, yet the data does not
indicate the number of new HIV infections, nor does it show
how and where these infections are occurring. According to
Gayle, "In order to get a clearer picture of the HIV/AIDS
epidemic in Massachusetts and across the country, there is
a need for improved data on HIV". She warns that people
should be careful not to be misled by the decreasing number
of AIDS cases and stresses the critical need for HIV
prevention.
Holding AIDS at Bay, Only to Face 'Lazarus Syndrome'
New York Times (10/06/98)
Protease inhibitor therapy has helped to increase the
lifespans of many HIV-infected people, only to leave them
attempting to adjust to what is--for many--life after death.
A number of patients have seen their friends die from AIDS,
and they face a harder life with the virus. Patients may face
financial difficulties due to the cost of treatment or anxiety
over the end of romantic relationships; some even become
suicidal. Researchers have dubbed this anxiety the Lazarus
Syndrome, named after the biblical figure who was raised
from the dead by Christ.
Dr. Judith Rabkin, a professor of clinical psychology at
Columbia University, estimates that tens of thousands of
HIV-infected people may have the syndrome. While the rigid
medical regimen of protease inhibitor treatment may not
directly cause the syndrome, it can contribute to the
anxiety. Researchers note that the syndrome is unique to
AIDS, but liken it to feelings of trauma suffered by Holocaust
survivors. Both groups have seen their friends and families
die and expected that they too would die, but were saved
instead. Some advocacy groups are offering counseling to
help patients deal with their emotions.

~
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by MIKE MARTIN
Fall is a season of change. The
leaves are changing colors to magnificent shades of red and yellow and
orange. Some wag once said that
"change is the only constant." Well, I
guess that's just about right.
There have been a couple of staff
changes at The AIDS Project. On the
plus side, David Swander has joined the
staff... now I mentioned this last month,
but I want to make sure he feels really
welcome. David has taken on the
additional duty of making sure this
newsletter gets distributed. Thanks,
David! And on the not-so-plus side,
Rodney Mondor has left the Project for
a job with the University of Southern
Maine. Rodney brought a lot of energy
and heart to his work as the Volunteer
Services Coordinator. And he recently
completed the Boston to New York
AIDS Ride, for the second year in a row.
Anyway, we'll miss his cheerful
attitude and can-do enthusiasm. Good
luck, Rodney!
When you visit the Portland office
of TAP, you will notice some changes in
the lobby area. The changes are
designed to provide even more professional service to clients and to improve
on clients' comfort levels around
confidentiality.
On page five, I've reprinted TAP's
Client Rights and Grievance
Procedures. They haven't changed
much over the years. Whoever wrote
them did a pretty good job. Still, a
refresher dose never hurts.
On page six, I've reproduced a chart
outlining anti-HIV drugs' dosages from
Proj,ect Inform. I do so as a little service
to clients because a client recently told
me about how his doctor had underprescribed one of his drugs and how the
Sources for some of the material in this
newsletter include:

client had built up a drug resistant
because of this under-dosing. Of
course, I recommend to all clients that
they carefully consult and question their
doctors when it comes to taking meds.
One thing we know for sure, if you
aren't taking the right amount of these
drugs, you can build up a resistance
pretty quickly. The treatments for HIV
are constantly changing, with more
options than ever before. But they won't
do you any good, if you don't get them
right.
For those of you who participated in
the Reconstruction programs this
summer, I talked with Randy Norcross
of the Maine AIDS Alliance and he tells
me that followup from those sessions is
in the thinking stages. In particular, the
issues of going back to work and dating
are on the list of things clients would
like further workshops to address.
A pleasant change was not that this
year's Women's Leadership Luncheon
was a big success (previous ones have
been successful), but that the amount
raised to benefit TAP in its work with
people with HIV/AIDS was significantly higher than last year. It was a
grand event, and very moving. My
congratulations to all who made it such
a wonderful experience.
Speaking of change, TAP will pick
up a nice piece of change ($$$) through
the sale ofWCLZ 98.9's "Homegrown,
Volume 3" CD of local musical talent.
Two dollars from each CD sold will be
donated to TAP. They are available at
Bull Moose Music stores. Thanks to
WCLZ and Bull Moose Music for
choosing TAP to be this year's recipient
of their largesse.
Change can be a good thing.
Sometimes a very good thing.

L

The CDC Daily AIDS Update/Prevention News
Project Inform, San Francisco, CA
The next issue of In The Affirmative:
Mid-November 1998
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More HIV News
Reporting HIV Casas Discussed
Augusta Chronicle Online (09/23/98)
Health officials in Georgia met in September to discuss
the use of HIV reporting in the state. A decision on the
matter is expected to be ready by summer 1999. Georgia is
one of 11 states that does not currently report HIV cases.
The state does report AIDS cases, but David Johnson, of the
STD/HIV section of the Division of Public Health, said, "AIDS
cases tell us what may have occurred 8-10 years ago, not
what's occurring recently." Johnson also noted that the lack
of HIV reporting could give people the false sense that the
HIV epidemic is declining, since AIDS cases and AIDS
deaths are falling. Some people voiced concerns that nameor code-based HIV reporting would keep people from
getting tested for HIV. There are an estimated 25,000 to
30,000 HIV-infected individuals in Georgia, according to
state officials.
Reporting HIV Cases Is Urged at Hearing
Boston Globe Online (09/23/98)
Several AIDS activists spoke in favor of non-name based
reporting of HIV cases at a hearing in September in
Massachusetts. The measure discussed would require the
reporting of HIV cases to the state Department of Public
Health using a 17-digit identifier code that would encode
information relating gender, age, and residence of the
infected patient. Physicians would also be required to
submit similarly coded information on patients already
diagnosed with HIV. Bennett Klein, AIDS law project
director for Gay and Lesbian Advocates and Defenders,
asserts that "a non-name-based HIV reporting system
responsibly balances the goal of obtaining more accurate
and complete information about the HIV epidemic with the
critical need to encourage HIV testing." Some fear that the
system, which would go into effect on January 1, would
result in the duplication of case reports, while others
opposed the plan completely, arguing that name-based
reporting is necessary in order to conduct partner
notification.
AIDS Deaths in U.S. Drop by Nearly Half
New York Times (10/08/98)
The AIDS mortality rate in the United States decreased
by 46.4 percent in 1997, according to new data from the
National Center for Health Statistics. There were 16,865
deaths due to AIDS in 1997, as compared to 31, 130 deaths
in 1996. The mortality rate decreased by a much greater
margin than the previous record decrease, which measured
29 percent from 1995 to 1996. The death rate fell to the
lowest level since 1987--the first year AIDS deaths were
tracked. AIDS ranked as the eighth leading cause of death in
the United States in 1996, but fell to the 14th leading cause
in 1997.
However, the number of new HIV infections remained
stable at about 40,000, indicating that there is a larger
population of people living with the virus. The longer
lifespan of infected people also means that there is an
increased risk of the spread of the virus. Furthermore, some
experts worry that the good news about the decrease in
AIDS mortality will cause complacency. Health and Human
Services Secretary Donna E. Shalala said the decline
"reflects the tremendous power of the new combination
therapies, the enormous effort to get the drugs to people
and the huge Federal effort to pay for these drugs. What this
also tells us is that we have serious problems when we
have not brought down the rate of new infections." Some
researchers note that they are particularly concerned that
while the decline in AIDS mortality shows great strides
forward in treatment, prevention efforts have not been
similarly successful because the number of new infections
has remained level.

Wave of Laws Aimed at People Wrth HIV
New York Times (09/25/98)
Nationwide, laws that affect people with HIV are being
passed following public fears about the spread of the
disease. For example, at least 29 states now have laws
making it a criminal offense to knowingly transmit HIV;
one-third of the states adopted those laws within the last
two years, and 16 states introduced such measures this
year. Many states are also requiring HIV testing of certain
populations, most notably prisoners and pregnant
women.
Four states recently passed laws allowing good
Samaritans and non-medical personnel the right to inquire
about the HIV status of the people they assist. Other states
are increasing partner notification systems. According to
some experts, the new laws result from a change in
attitudes toward infected people; they also stem from
growing publicity concerning specific cases of HIV
transmission, such as the case of Nushawn Williams,
who is accused of knowingly infected over a dozen girls
and young women in New York. Lawrence 0. Gostin, a
director of the Georgetown University-Johns Hopkins
University Program on Law and Public Health and a
member of the Centers for Disease Control and
Prevention's advisory committee, said, "Legislators
believe we have been soft on the epidemic, that we
haven't treated AIDS like other infectious diseases, and
the way they interpret it is a need to get tough on people
with AIDS."
The shift in public opinion is also tied to the change in
prognosis for HIV-infected people. Protease inhibitor
treatment has changed the perception of HIV infection
from what was viewed as a fatal condition to a seemingly
chronic disease. Additionally, a recent national phone
survey of over 1, 700 people found that the public has
become more suspicious of infected people, with 55
percent of respondents in 1997 believing that they can
contract HIV by sharing a glass with an infected person
and 41 percent saying the virus might be acquired through
the use of public toilets. Comparatively, 48 percent of
respondents in 1991 believed they could get HIV through
the sharing of a glass, while 34 percent thought they could
get HIV from using public toilets.
One of the authors of the study, social psychologist Dr.
Gregory M. Herek, noted that the erosion of information
could indicate that recent public health efforts have not
underscored the fact that HIV is transmitted via sexual
contact, contaminated hypodermic needles, or blood.
Many public health officials are worried about the new
criminalization laws and believe that the trend could result
in HIV-infected people shying away from help.
Maine Mother Is Allowed to Withhold AIDS Drug
Washington Post (09/15/98)
Recently, a Maine judge ruled that Valerie Emerson of
Bangor, Maine has the right to refuse drug treatment for
her HIV-infected four-year-old son, Nikolas. Emerson
denied her son treatment, fearing that the powerful
treatment would kill her child.
The judge also ruled that Emerson could keep custody
of the child, instead of turning the boy over to the state
Department of Human Services. Emerson -- who is HIVpositive and does not take medication either - said her
decision stemmed from the death of her three-year-old
daughter while on AZT, noting that she did not want
Nikolas to go through the same process.

State Agency Backs Off HIV Names Proposal
Chicago Tribune Online (09/25/98)
The Illinois Public Health Department has reversed a
decision to require the names of HIV-positive people and
will instead track HIV cases using non-name-based
identifier codes. The decision came after months of public
hearings and discussions with AIDS advocacy groups.
AIDS advocates had expressed concern that the
confidentiality of the reported individuals may be at risk.
The health department said that it wanted to reach a
compromise between activist concerns and surveillance
needs. Officials noted that the new plan could be changed to
name-reporting if it does not succeed; the pilot program will
be launched on July 1, 1999, and evaluated in mid-2001.
Chet Kelly, chief of the HIV/AIDS section for the
Department of Public Health, said, ''There's no way to
predict how it will work. If we didn't think it had any
opportunity for success, we wouldn't propose it."
DuPont Gets FDA Clearance For AIDS Drug
Wall Street Journal (09/21/98)
DuPont's pharmaceuticals division received FDA
approval Friday to market its once-daily AIDS drug Sustiva,
which the company says is as effective as the protease
class of medicines when used with AZT and 3TC. The drug,
which some analysts believe could generate $700 million in
revenue a year, is the third non-nucleoside reverse
transcriptase inhibitor (NNRTI) approved by the agency and
is priced at about $11 a day in order to compete with
protease drugs. Because the drug only needs to be taken
once a day, DuPont believes Sustiva, a brand of efavirenz,
will improve patient compliance and create a new standard
of care.
AIDS Group Protests DuPont's Pricing of New Drug
Boston Globe Online (09/25/98)
AIDS activists are protesting DuPont's decision to price
its new AIDS drug, Sustiva, between $4,000 and $5,000,
which some say could push individual drug therapy costs to
about $30,000 per year. Members of ACT UP Philadelphia
rallied outside DuPont's Wilmington, Del., headquarters,
dumping empty pill bottles from a black coffin to underline
its point. DuPont maintains that the drug is priced in the
middle of the range for HIV/AIDS antivirals, and said it tried
to price the drug so that the cost would not hinder access. In
addition, the company said it would expand its therapy
assistance program for the poor.
Sustiva, which studies showed is as effective as
Crixivan when taken in combination with AZT and 3TC, can
lower the number of drugs patients take daily.
Huge Gains and Huge Worries on AIDS
New York Times (10/09/98)
The medical advances that led to a 47 percent decline in
the AIDS mortality rate last year are remarkable, yet there
are still many HIV-infected individuals, according to an
editorial in the New York Times. As many as 900,000 people
in the United States carry the virus, with the rate of new
infections steady at about 40,000 cases a year. With
infected individuals living longer, the author argues that
''there is an increasing danger that they will pass the virus
on to others." The author also notes that HIV is spreading at
alarming rates in parts of the developing world. where
treatment access is very limited and financially restricted.
Until a vaccine against the virus is created, the author
contends that the HIV epidemic will continue to spread.

Notice: Dignity/New England is sponsoring "A Time Apart-A Day for Caregivers."
This event is free and open to anyone involved in the care of a person with AIDS, and will be held on
Saturday, October 31, 1998 from 9 am to 5 pm at St. Luke's Cathedral at 143 State Street in Portland. Lunch
and a massage therapist will be available. Call 646-2820 to register.
·-A ~
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More HIV News
African Growth Slows as Deaths Multiply
Philadelphia Inquirer (09/27/98)
United Nations demographers report that the effect of
the AIDS epidemic on the population in some areas of Africa
will be "unbelievable," according to one. Revised UN
estimates for population growth will be released at the end
of October, and some population experts believe that
several countries in the region will reach zero population
growth in a few years due to a combination of AIDS, food
shortages, water depletion, social chaos, and ecological
collapse.
Zimbabwe is expected to be the hardest hit by the AIDS
epidemic, with one-quarter of the population believed to be
infected with HIV. Botswana also reportedly has a 25
percent infection rate, while Namibia has a 20 percent rate,
Zambia has a 19 percent rate, Swaziland has an 18.5
percent rate, and several other African nations have rates
over 10 percent. However, the spread of HIV is apparently
slowing in some other countries, such as the United States,
Brazil. Thailand, and Uganda.
Worldwide population growth is expected to continue,
with the population expected to reach 6 billion by mid-1999.
AIDS on Rise Among SO-and-Overs
Miami Herald (09/27/98)
According to the Florida Department of Elder Affairs, 10
percent of all AIDS cases in the United States occur in
people over the age of 50 years, with rates reaching 12
percent to 14 percent in Florida. Of 67,282 AIDS cases in
Florida, 8,400 patients are age 50 or over. Despite these
numbers, older people are often not considered at risk for
HIV.
Sue Saunders - a 65-year-old Fort Lauderdale woman
with AIDS - started the AIDS activist group Senior HIV
Intervention Project in response to this risk, receiving
$170,000 from the Department of Elder Affairs to run a
prevention group focusing on older people. Following the
success of the initial program, the project spun off and a
second group was formed in the Tampa Bay area. Saunders
notes, ''You're never too old [to contract HIV]. And all it takes
is one partner-if he or she is infected."
Lower-Dose Regimen Works for Protease Inhibitor
Reuters (09/25/98)
Patients with AIDS may soon be able to take two doses
of the protease inhibitor Viracept instead of three, Agouron
said recently. The drug maker said 80 percent of 238
patients taking a higher, twice-daily dosage of Viracept as
part of a drug cocktail were able to lower the levels of the
virus to a level that was almost undetectable. The response
was similar to that achieved by patients taking the drug
three times a day in a lower dosage. If the drug is approved,
it may erode market share now held by Merck's Crixivan.
Postexposure Treatment Not Easy to Swallow
AIDS Alert (09/98)
According to research by the Centers for Disease Control
and Prevention, approximately one-third of health care
workers who undergo HIV postexposure prophylaxis
treatment {PEP) do not complete their regimen. Seventyfive percent of the workers who halted treatment cited side
effects as the determining factor. Side effects were also an
issue with exposed workers who decided not to receive the
treatment; only 58 of 114 exposed workers opted to receive
PEP in the study.
Research presented at the 12th World AIDS Conference
in Geneva indicated that at least half of 100 occupational
exposures to HIV investigated could have been prevented
through proper work practices.

Page Four

U.S. House of Representatives' AIDS Notification
Measure Praised, and Attacked by Prominent Groups
Washington Times (09/30/98)
At a House hearing in late September, the HIV Partner
Protection Act -- which would require HIV-infected people
to be reported confidentially by name instead of
anonymous codes --was both praised and criticized.
The bill, co-sponsored by Rep. Tom Coburn {R-Okla.)
and Gary L. Ackerman {D-N.Y.). would also require doctors
to supply the names of sexual partners named by the
infected person to public health professionals, who could
then notify those individuals. Ackerman told the House
Commerce subcommittee on health and environment that
the bill was particularly important for women, because
many women with HIV were infected by partners who
engage in high-risk behavior. However, Dr. Helene D.
Gayle, head of the National Center for HIV, STD, and TB
Prevention at the Centers for Disease Control and
Prevention, asserted that the bill may cause people to
avoid testing altogether due to confidentiality concerns.
Gayle also noted that partner notification must be dealt
with carefully, because it could result in domestic
violence.
Critics of the bill included the American Civil Liberties
Union, AIDS Action, and the Association of State and
Territorial Health Offices. The measure's supporters
include the American Academy of Family Physicians; and
directors of AIDS outreach programs in Florida, Brooklyn,
New York, and Los Angeles.
Patient Participation in HIV Treatment Plans
Recommended to Improve Adherence
Reuters Health Information SeNices (10/08/98)
Dr. Barron H. Lerner, of Columbia University College of
Physicians and Surgeons in New York City, and fellow
researchers report in the October 1st issue of the Annals
of Internal Medicine that anti-HIV drug regimen adherence
may be increased by personalizing patient medication
plans. The researchers recommend that patients first
receive educational materials on the drugs, then the
doctors should determine what patient lifestyle habits
could affect adherence, and finally the patients should
undergo a test regimen with dummy pills.
The authors discourage strict categorization of patients
as either adherent or non-adherent. They note that more
flexible labeling and active participation by the patient in
the regimen can prevent judgmental and inaccurate
behavioral assessment and could increase treatment
adherence.
People Must Prove Exposure to HIV Before Suing,
Supreme Court Says
Postnet Online (10/02/98)
The Illinois Supreme Court has ruled that patients who
groundlessly feel they were put at risk for HIV due to
medical care are not entitled to monetary damages. The
court ruled against a woman who was cut by a scalpel in
the office of an HIV-infected podiatrist. The woman, who
worked as an aide in the office and cut herself while
emptying a used sharps container, sued the two doctors
at the office over fears that she may have been infected.
The court also ruled against six patients who were treated
by an HIV-positive dental student at Northwestern
University.
The judges said that proof of exposure is necessary to
warrant damages and that fear of exposure was
insufficient for compensation. David Holmes, one of the
lawyers who represented one the defendants, said, "It's
important that the justices draw the line. There's a lot of
hysteria about AIDS." None of the plaintiffs contracted
HIV, the virus that causes AIDS.

Citing Privacy Rules, California Governor Wilson Vetoes
Bill on HIV Reporting System
•
San Francisco Examiner Online (10/01/98)
California Gov. Pete Wilson has vetoed legislation that
would require the creation of a statewide HIV reporting
system. San Francisco AIDS activists and public health
officials expressed dismay at Wilson's action, asserting
that the system would have been beneficial to public health.
Wilson contends that the measure was flawed since the
system would not be name-based and that "concerns over
confidentiality and discrimination should not be used to
justify an inadequate reporting system."
California is one of nine states that does not require HIVreporting. Wilson, who is ending his final term this year, also
signed a number of related bills this week, including a bill
that mandates prison time for people convicted of
knowingly transmitting HIV, a measure that requires
emergency regulations for health care workers who sustain
needlestick injuries, and a plan to institute a new red-ribbon
license plate to raise money for AIDS research at the
University of California.

PRO.JECT

Support Groups
Looking for
New Members
Both the Tuesday morning and Thursday
evening support groups sponsored by The
AIDS Project are looking for new members.
Both groups offer a safe and supportive
space to share, listen, and connect with
others. Please contact Susan Parr, TAP Case
Manager, at 77 4-6877 for more info.
The Tuesday morning group is open to
anyone who is infected or affected by
HIV/AIDS. The group serves family members,
partners, relatives, and friends of those living
with HIV/AIDS, along with persons lving with
HIV/AIDS. Meetings are every Tuesday from
10:30 a.m. to 12:00 noon in Suite 632 (TAP's
Meeting Place) at 142 High Street in Portland.
Joan Murray and Frannie Peabody facilitate
the group.
The Thursday evening support group is open
to people living with HIV/AIDS. The group
meets every Thursday from 5:30 p.m. to 7:00
p.m. in Suite 632 (TAP's Meeting Place) at
142 High Street in Portland. Audni Miller
facilitates this group.
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Reviewing Client Rights and the Client Grievance Procedures
Editor's note: From time to time I try to resubmit information in this newsletter that directly pertains to client
needs. Basic to the relationship ofclients to The AIDS Project is how clients are treated and what rights they have
concerning the policies and services of The AIDS Project. So,for your information, here is information I think
all clients should have at their disposal.

Client Rights
·1

,I

As a client ofThe AIDS Project you have certain rights. They include:
1. Considerate and respectful care. The right to receive considerate, dignified, and respectful treatment and care
regardless of your physical or emotional condition, by all AIDS Project staff, interns, and volunteers.
2. To be informed. The right to be informed of what services the agency provides, the method for obtaining those
services, and the reasons why a service is not being provided.
3. A reasonable and timely response. A response by a staff member in a reasonable and timely manner to your
request(s) for services.
4. Nondiscrimination. The right to quality services without discrimination as to race, color, age, disability, homelessness, religion, sex, national origin, economic status, or sexual orientation.
5. Confidentiality. The right to expect that The AIDS Project will maintain the confidentiality of charts and records
pertaining to the services you receive(d), except for otherwise provided by law. Any exceptions of confidentiality shall
require you or your designee to sign a release of information. This does not apply to statistical data, which is required by
funding agencies where the client's identity is not made known.
6. Accessibility to your file. The right to request to review your file at a mutually agreed upon time with your case
manager. Clients also have the rightto request a photocopy oftheir records.
7. Grievance. The right to a formal grievance procedure in the event that you feel your rights as a client have been
violated.

Grievance Procedures
The AIDS Project recognizes the importance of client rights with regard to the delivery of services which affect
them. In keeping with this view, The AIDS Project has established grievance procedures through which clients may voice
their concerns should an issue of dispute arise concerning policy or service delivery.

1
J

1. The first step in any grievance procedure is to address the issue directly with the person(s) involved, [such as
client and case manager].
2. If the parties directly involved cannot resolve the dispute within 5 working days, the matter will be described in
writing* by the grieving party to the program coordinator, [such as the Director of Support Services]. The coordinator shall
attempt to achieve resolution with the parties involved.
3. If, within 5 working days, the dispute still exists, the coordinator shall notify the Executive Director in writing. The
Executive Director shall decide all matters related to the dispute within 15 days and provide the client written notification.
4. If the grievance is not resolved to the satisfaction of the client, he or she may submit a written request to the
President of the Board of Directors. A final binding decision will be made within 30 days of receipt of this request.
*Persons voicing grievances regarding anonymous testing may do so using their client number, in order to protect
their anonymity.
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Standard Dosing Schedule for Anti-HIV Drugs (from Proiect Inform)
Name

Brand Name

Class

Standard Daily Dose

Comments

lndinavir

Crixivan®

Protease
Inhibitor

Two 400-mg capsules
three times a day

Take on empty stomach, at least 1 hour before or 2 hours after a meal; do not
take at same time as ddl, take indinavir at least 1 hour before or 2 hours after
ddl; to reduce risk of kidney stones, drink 8 glasses of water a day; must be
taken every 8 hours.

Nelfinavir

Viracept®

Protease
Inhibitor

Three 250-mg tablets
three times a day

Should take with food; diarrhea is a common side effect that is usually
controlled with over-the counter medication.

Ritonavir

Norvir®

Protease
Inhibitor

Six 100-mg capsules
twice a day

Diarrhea and nausea may appear, is worse in first few weeks; needs to be
refrigerated, consult doctor for initial dosing schedule (start at 300-mg twice
a dayfor2 days and increase 100-mg every 2 days until you reach 600-mg).

Saquinavir

Fortovase®,
lnvirase®

Protease
Inhibitor

Fortovase - Six 200-mg capsules
three times a day
lnvirase -Three 200-mg capsules
three times a day

Take with food, within 2 hours of high fat meal; diarrhea and nausea are rare
side effects.

Delavirdine

Rescriptor®

NNRTI

Four 100-mg tablets
three times a day

Take with or without food; can be dissolved in water or other liquids if drank
immediately; a severe rash could develop (usually within first 3 weeks) and
require hospitalization or milder rash which can be controlled by antihistamines or topical agents.

Nevirapine

Viramune®

NNRTI

1 200-mg tablet
twice a day

Dose usually starts at one 200-mg tablet and then increased to two 200-mg
tablets after 14 days; take with or without food; a severe rash could develop
(usually within first 3 weeks) and require hospitalization or milder rash which
can be controlled by antihistamines or topical agents.

AZf

Retrovir®,
zidovudine

NARTI

Two 100-mg capsules
twice a day
or 1 300-mg tablet
twice a day

Take with or without food; common side effects (which diminish after 6 to 8
weeks) include headache, nausea, and a general sense of feeling ill; most
serious side effect is anemia, if caught early can be treated with erythropoietin(EPO).

AZf +3TC

Combivir®

NARTI

1tablet (with 150-mg 3TC, 300-mg AZT)
twice a day

Take with or without food; see comments in AZf and 3TC sections.

ddC

Hivid®,
zalcitabine

NARTI

Three 0.75-mg tablets
three times a day

Take with or without food; side effects can include pain or tingling in hands
and/or feet, low platelets, and mouth sores; the most serious side effect is
pancreatitis, which has been fatal in some people -- symptoms include sharp
pain in upper abdomen, nausea, and vomiting, stop drug immediately and
consult your doctor. Alcohol use increases risk of pancreatitis.

ddl

Videx®,
didanosine

NARTI

Two 100-mg tablets
twice a day

Take without food and on an empty stomach; do not take within 2 hours of
drugs that require an acidic stomach environment, including many protease
inhibitors and drugs such as dapsone; side effects could include increased
uric acid levels (kidney function), headaches, sleeplessness, diarrhea, and
pain and/or tingling in hands and/or feet; the most serious side effect is
pancreatitis, which has been fatal in some people -- symptoms include sharp
pain in upper abdomen, nausea, and vomiting, stop drug immediately and
consult your doctor. Alcohol use increases risk of pancreatitis.

d4T

Zerit®,
stavudine

NARTI

Two 40-mg capsules
twice a day

Take with or without food; common side effects are pain and/or tingling in
hands and/or feet and anemia; a rare, but serious side effect is pancreatitis,
which has been fatal in some people -- symptoms include sharp pain in upper
abdomen, nausea, and vomiting, stop drug immediately and consult your
doctor. Alcohol use increases risk of pancreatitis.

3TC

Epivir®,
lamivudine

NARTI

Two 150-mg tablets
twice a day

Take with or without food; side effects are rare, but may include headaches,
nausea, general sense offeeling ill, diarrhea, anemia, and hair loss.

~

NNRTI = Non-nucleoside reverse transcriptase inhibitor NARTI = Nucleoside analogue reverse transcriptase inhibitor
For more info, call the National HIV/AIDS Treatment Hotline at 1-800-822-7422
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MEDICAL ASSISTANT FUNDS
An important reminder to clients:
There are funds available to TAP clients with financial need for the
following items: Routine Dental Care, Routine Eye Care and
Eyeglasses, Vitamin Supplements, Non-Prescription Skin Care
Products, and Non-Medicaid Medication Co-pays.
There is a dollar limit to how much a client can receive in any fiscal
year. Contact your case manager for assistance.

FREE LUNCH
Enjoy a free lunch at The AIDS Project every Thursday at noon. Join
other clients and TAP staff for a great meal, good conversation, and
very good company. Drop on by Thursdays at noon!

IMMEDIATE SEATING
For free tickets to area events as they become available, sign up for
"Immediate Seating." Call TAP at 774-6877 for more information.

I.V LEAGUE
Meetings of the I.V. League support group are held on
Wednesdays at 11 :00 a.m. at the Parkside Community
Center, 94 Mellen Street, in Portland.
For more information, call 874-8775.

THE MEETING PLACE
This room is used by TAP in Portland for support groups, counseling
and testing, and some clienVcase manager meetings. Located in
Suite 632, it provides more privacy for people served by TAP.
Enter from the High Street side of the building.

11111;u1ll)#JINFORMATION I
HIV WEBSITES
Check out these websites:
www.hivpositive.com
www.thebody.com
www.projinf.org
for info on HIV and AIDS.

TAP ON-LINE
Visit our web address at
"www.aidsproject.org"
To e-mail The AIDS Project,
send your message along to
"tap@aidsproject.org"

AIDS HOTLINES
Questions about
HIV/AIDS?
Call toll-free
National AIDS Hotline:
1-800-342-2437
Maine AIDSline:
1-800-851-2437
Maine Teen Hotline:
1-800-851-2437

TAP's MAILING ADDRESS
When writing to TAP in Portland, please send your mail to our post
office box. It really rushes mail delivery if letters are not addressed
to our street address,
so write us at P. 0. Box 5305,
Portland, ME 04101
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FOR PEOPLE INFECTED
AND AFFECTED BY HIV/AIDS

TUESDAYS
Time: 10:30 a.m. to noon
Group: HIV Infected/Affected Drop-In Support Group
A meeting for people living with and affected by the virus.
Location: Portland, TAP, The Meeting Place, Suite 632.
Contact Randy May at TAP at 774-6877 for more information.
Time: 1:30 p.m. to 3:00 p.m.
Dates: Starts September 22nd, Meets every other Tuesday
Group: Women with HIV
A bi-weekly meeting of women living with HIV.
Sponsored by The AIDS Project (TAP)
and The AIDS Consultation Service (ACS)
at Maine Medical Center.
Location: Portland, ACS, 52 Gilman Street.
Contact Janine Collins at TAP at 774-6877
or Cindy Luce at ACS at 871-2991 for more information.
Time: 1:30 p.m. to 3:00 p.m.
Group: People Uving with HIV
An ongoing drop-in support group for people living with HIV.
Location: Auburn, TAP, One Auburn Center.
Contact Diana Carrigan at TAP at 783-4301 for more info.

THURSDAYS
Time: 10:00 a.m. to 11:30 a.m.
Group: HIV Infected/Affected Drop-in Group
A TAP-sponsored meeting for people
living with and affected by HIV/AIDS in southern Maine.
Location: Sanford, Unitarian Church, located at the corner of
Main St. (Rte. 109) and Lebanon St. (Rte. 202).
Contact Getty Payson at TAP at 985-8199 for more info.
Time: 12 noon
Group: Open Lunch for TAP Clients/Staff
An informal luncheon gathering of TAP staff and clients.
Location: Portland, TAP, Conference Room.
Contact Randy May at TAP at 774-6877 for more information.

Time: 5:30 p.m. to 7:00 p.m.
Group: People Living with HIV/AIDS
A drop-in support group for anyone with HIV/AIDS.
Location: Portland, TAP, The Meeting Place, Suite 632.
Contact Randy May at TAP at 774-6877 for more information.
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The AIDS Project
615 Congress Street
(or 142 High Street)
P.O. Box 5305
Portland, Maine 04101
Phone: 774-6877 Fax: 879-0761
E-mail: tap@aidsproject.org
Website: www.aidsproject.org
AIDS Hotline: 775-1267
or 1-800-851-2437
Oxford/ Androscoggin Cty. Office
One Auburn Center/Box 14L
Auburn, ME 04210
Phone: 783-4301 Fax: 795-4084
York County Office
Lafayette Center • 4th Floor
Kennebunk, ME 04043
Phone: 985-8199 Fax: 985-8646 *51
Staff:

Doug Bailey,
HAVEN Project Coordinator
Declan Buckley,
Prevention Ed Outreach Worker
Diana Carrigan,
Case Manager
Janine Collins,
Case Manager
John Cronin,
Prevention Ed Outreach Worker
Sequoia Dance,
Prevention Ed Outreach Worker
Douglas Eaton,
Prgrm. Coord./HIV Prevention
Jill Frame,
HAVEN Case Manager
George W. Friou,
Executive Director

Demetra Giatas,
Development Director
John Green,
Case Manager
John Holverson,
Director of Policy & Program
Randy May,
Director of Support Services
Rebecca Neel,
Case Manager
Susan Parr,
Case Manager
Getty Payson,
Case Manager
Linda Pfaffinger,
Community HIV Prevention Ed
Steve Reevy,
Di rector/Finance/Administration
Gerry Scoppettuolo,
Prevention Ed Outreach Worker
David Swander.
Administrative/Development Asst.
Arthur Waller
Accounting Assistant
Board of Directors:
Joel C. Martin, Esq., President
Michael Martin, Vice President
Anne M. Romano, CPA, Treasurer
JoAnne Peterson, Secretary

Lawrence Bliss
Michael Burnham
Jerrold C. Edelberg, Ph.D.
Dino Giamatti
Judi Mansing
Karla B. McGowan
Frances W. Peabody
John Wade
Christopher Warner

IIIIIIIIAFFIRMATIVI
In The Affirmative is a monthly newsletter published by The AIDS
Project for people living with and affected by HIV/AIDS. Letters, articles,
or other submissions should be sent to: In The Affirmative, c/o The AIDS
Project, P.O. Box 5305, Portland, ME 04101, or call (207) 774-6877.
Submissions can be printed anonymously as long as the person
submitting the material includes his or her name and phone number for
verification.
News, information, and features are as up-to-date as possible prior to
publication. Any medical information included in this newsletter is
submitted for the reader's information only, to be used as the reader so
chooses.
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Verne Weisberg, M.D.
Roberta M. Wright
Advisory Board:
Bettsanne Holmes, Chair
Josiah K. Adams
Peter C Barnard
Joan B. Burns
Peter L. Chandler, CPA
Madeleine G. Corson
Maria P. Damerel
Josiah H. Drummond, Jr.
Alice Gemmer
Pamela W. Gleichman
Sandra Goolden
Celeste Gosselin
Jonathan W. Karol, D.O.
Leo J. LaPlante, CPA
Pamela Knowles Lawrason, Esq.
George M. Lord
Mallory K. Marshall
Mary Jean Mork
Gwendolyn C. O'Guin, D.O.
Patricia M. Pinto
Lois Galgay Reckitt
Victoria A. Rochefort
Lynn E. Shaffer
Elizabeth 0. Shorr
John H. Siegle, M.D.
Cynthia Sartwell, M.D.
Seth Sprague
James F. Tomney
Virginia W. Truesdale
Margaret Wiles
Jean T. Wilkinson
Margo Wintersteen
Roger F. Woodman
Frances R. Zilkha

Contributors include:
Karla McGowan
Susan Paar
Jill Tacy
People Art
© David Cedrone
David Swander, Distribution
Mike Martin, Editor
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